FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
Scientists at Centers for Disease Control and Prevention describe research in anthrax vaccines
March 15th, 2007
Data detailed in "Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed" have been presented. "In 2002, the Centers for Disease Control and Prevention established the Vaccine Analytic Unit (VAU) in collaboration with the Department of Defense (DoD). The focus of this report is to describe the process by which the VAU's anthrax vaccine safety research plan was developed following a comprehensive review of these topics," researchers in the United States report. "Public health literature, surveillance data, and clinical sources were reviewed to create a list of adverse events...
Source: FDA Law Weekly (2007-03-15)
|
